Abiopharma

Immuneering Appoints Andrew Gengos as Chief Financial Officer

Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome

10 Barrel Brewing and Pub Beer Kick Off Pacific Northwest Summer of Soccer Celebration

Plains All American Pipeline and Plains GP Holdings Provide Updated Capital Spending Guidance for 2026

Dragonfly Energy Receives European Patent Allowance for Advancing Dry Electrode and Solid-State Battery Manufacturing

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

Anfield Energy Announces a Key Milestone in Equipment Procurement, Advancing the Company Towards Hub-and-Spoke Production

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

Shuv Energy’s announcement that it is prevented from advancing the handling of the offer in light of its commitment to an exclusivity period